| November 13, 2009 | News for the retail pharmacy industry |
 |  |
| Daily Dose |  |  |
|
- Hamburg: FDA is working to boost efficiency of drug regulation
FDA Commissioner Margaret Hamburg said she will visit China next year to look into safety policies related to imported products. The agency is hiring more staff, leveraging science and working on other means to speed up drug-approval reviews, Hamburg said at the Reuters Health Summit. Reuters
(11/12)      
| Health & Wellness | | |
|
- WHO: Give antivirals early to groups vulnerable to H1N1 flu
The World Health Organization urged doctors to give antiviral drugs, such as Tamiflu, to at-risk groups, including pregnant women and young children, at the first sign that they have H1N1 flu to avoid serious complications. WHO said doctors need not wait for laboratory results to confirm the disease. The organization also said the advice applies to "otherwise healthy people who show progressive symptoms." Google/The Associated Press
(11/12)
- Obese more likely to have uncontrolled asthma
Obese patients with asthma are more likely to have uncontrolled disease than are normal or overweight people with the chronic condition, Cleveland Clinic researchers said. However, obese patients didn't have increased airway inflammation or constriction, suggesting that a lack of asthma control may be a function of body mass index rather than other factors of the disease. MedPage Today (free registration)
(11/11)
| Industry News | | |
|
- GSK chief sees H1N1 pandemic as recurrent business
The H1N1 flu pandemic likely will be a sustainable and "very significant business" for GlaxoSmithKline until the second quarter of next year, as more countries stockpile vaccines and antivirals, CEO Andrew Witty said. "I think what that will lead to is a lower level, but still I think a material level, of potential sales to government stockpiling environments over the next few years," Witty said. Reuters
(11/12)
- Boehringer banks on experimental drug for female sexual dysfunction
Boehringer Ingelheim hopes to introduce a drug for female sexual dysfunction that blocks the release of serotonin -- a brain chemical that regulates mood, appetite, sleep and memory -- and in turn triggers the production of the neurotransmitter dopamine to stimulate desire. Clinical data on the compound, flibanserin, will be presented at the European Society for Sexual Medicine conference. Bloomberg
(11/12)
| Retail Update | | |
|
- CVS Caremark to retain model, seek new president for PBM segment
Tom Ryan, CVS Caremark chairman and CEO, said the company will retain its PBM model and is working to reverse the segment's underperformance. Speaking at a conference in Arizona, he discussed the successes generated by its PBM business and how CVS can boost drug compliance and promote cost-efficiency via generics use. The company is also looking for a new Caremark president to replace Howard McClure, who is retiring on Nov. 27. Drug Store News
(11/12)
- MinuteClinic celebrates National Nurse Practitioner week
CVS Caremark's MinuteClinic, one of the country's biggest nurse practitioner employers, is paying tribute to the care providers during National Nurse Practitioner week. "Our practitioners do a fantastic job with patient education, which has allowed the MinuteClinic model to evolve beyond acute care to include wellness and prevention services," said MinuteClinic's president. Drug Store News
(11/12)
| FMI News | | |
|
-
FMI, GMA, KSA Survey of Supply Chain Effectiveness Now Open for Participation
FMI and GMA are pleased to announce their partnership with Kurt Salmon Associates for the 2009 Survey of Collaborative Trading Partner Supply Chain Effectiveness. Retailer, wholesaler and manufacturer submitted survey results will be used to guide the work of the respective and joint supply chain committees for the next few years. To participate in this brief 15 minute survey, please contact jfinci@gmaonline.org.
|
| SmartQuote | | |
|
 | Defining and analyzing humor is a pastime of humorless people."
|
| |
| Advertise |
|
Sales Account Director:
Linda Blau 212-677-5795
|
|
|
| |
|
Read more at dailyLead.com |
|
A powerful website for dailyLead® readers including:
|
|
|
|
| |
| |
| | Recent FMI Pharmacy dailyLead Issues:
- Thursday, November 12, 2009
- Wednesday, November 11, 2009
- Tuesday, November 10, 2009
- Monday, November 09, 2009
- Friday, November 06, 2009
| | | Lead Editor: Elizabeth Collins
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | |
| |
|
| © 1999-2011 SmartBrief, Inc.® Legal Information |
|
